Sionna Therapeutics, Inc. (SION)
4.91
-0.19
(-3.73%)
USD |
NASDAQ |
Oct 02, 16:00
4.925
+0.02
(+0.31%)
After-Hours: 20:00
Sionna Therapeutics Net Income (Quarterly) : -29.89M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.89M |
| March 31, 2026 | -26.78M |
| December 31, 2025 | -20.44M |
| September 30, 2025 | -20.28M |
| June 30, 2025 | -18.07M |
| March 31, 2025 | -16.48M |
| Date | Value |
|---|---|
| December 31, 2024 | -15.85M |
| September 30, 2024 | -25.44M |
| June 30, 2024 | -8.552M |
| March 31, 2024 | -11.85M |
| December 31, 2023 | -11.88M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.100B |
| Capricor Therapeutics, Inc. | -40.73M |
| ARS Pharmaceuticals, Inc. | -62.34M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Immunic, Inc. | -34.10M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 29.89M |
| EPS Diluted (Quarterly) | -0.6619 |
| Enterprise Value | 18.79M |
| Earnings Yield | -44.18% |
| Normalized Earnings Yield | -44.18 |